Yahoo Finance 
Global Active Pharmaceutical Ingredients (API) Market Outlook 2022-2030: Key Market Opportunities, Major Roadblocks for the Market Growth, Regulatory and Standards Landscape, Industry Risk Analysis
Dublin, April 18, 2022 (GLOBE NEWSWIRE) -- The "Global Active Pharmaceutical Ingredients Market Outlook 2020-2030" report has been added to ResearchAndMarkets.com's offering.
The market is estimated to garner a revenue of near to USD 330 Billion by the end of 2030, up from a revenue of around USD 185 Billion in the year 2020.
The global active pharmaceutical ingredients (API) market is anticipated to grow with a CAGR of 6.08% over the forecast period, i.e., 2021 - 2030.
Factors such as the increasing number of generic drug approvals, followed by the growing demand for generic and biosimilar drugs, and the rising healthcare expenditure are anticipated to drive the growth of the market in the coming years.
Moreover, factors such as the rising prevalence of chronic diseases worldwide, which is driving the need amongst the pharmaceutical drug manufacturers to develop advanced medicines to treat these diseases, is also expected to drive the demand for active pharmaceutical ingredients (APIs) in the coming years, and in turn, contribute to the growth of the market.
The global active pharmaceutical ingredients (API) market is segmented by numerous segments, which include segmentation by type, synthesis type, therapeutic application, business mode, and by region.
Based on therapeutic application, the market is segmented into communicable disease, oncology, diabetes, cardiovascular disease, musculoskeletal disorders, respiratory disorders, and other therapeutic applications.
The cardiovascular disease segment is anticipated to garner the largest revenue of near to USD 70 Billion by the end of 2030, amongst all the other segments. Moreover, the segment generated a revenue of about USD 40 Billion in the year 2020.
The market in North America is anticipated to garner the largest revenue of more than USD 125 Billion by the end of 2030 amongst the markets in all the other regions. Moreover, in the year 2020, the market in the region registered a revenue of around USD 70 Billion.
Some of the prominent industry leaders in the market
Pfizer Inc.
GlaxoSmithKline plc
Novartis AG
Sanofi-aventis Groupe
Boehringer Ingelheim International GmbH
Aurobindo Pharma
Dr. Reddy's Laboratories Ltd.
API Corporation
Bristol-Myers Squibb Company
KATSURA CHEMICAL CO. Ltd.
Key Topics Covered:
1. Market Definition
1.1. Definition
1.2. Market Segmentation
2. Assumptions and Acronyms
3. Research Methodology
3.1. Research Process
3.2. Primary Research
3.3. Secondary Research
4. Executive Summary - Global Active Pharmaceutical Ingredients (API) Market
5. Market Dynamics
5.1. Market Drivers
5.2. Market Trends
6. Key Market Opportunities
7. Major Roadblocks for the Market Growth
8. Regulatory and Standards Landscape
9. Industry Risk Analysis
10. Pricing Analysis of Active Pharmaceutical Ingredients (API) Market
11. Industry Value Chain Analysis
12. Trade Outlook
12.1. Import
12.2. Export
13. Impact of COVID-19 on the Active Pharmaceutical Ingredients (API) Market
14. Product Feature Analysis
15. Competitive Positioning
16. Competitive Structure
16.1. Market Share Analysis, 2020
16.2. Competitive Benchmarking
16.3. Company Profiles
For more information about this report visit https://www.researchandmarkets.com/r/xwjzf8
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
